Nothing Special   »   [go: up one dir, main page]

GR3015374T3 - Ribozymes. - Google Patents

Ribozymes.

Info

Publication number
GR3015374T3
GR3015374T3 GR940403895T GR940403895T GR3015374T3 GR 3015374 T3 GR3015374 T3 GR 3015374T3 GR 940403895 T GR940403895 T GR 940403895T GR 940403895 T GR940403895 T GR 940403895T GR 3015374 T3 GR3015374 T3 GR 3015374T3
Authority
GR
Greece
Prior art keywords
ribozymes
Prior art date
Application number
GR940403895T
Other languages
Greek (el)
Inventor
Wayne Lyle Gerlach
James Phillip Haseloff
Philip Anthony Jennings
Fiona Helen Cameron
Original Assignee
Gene Shears Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27507391&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3015374(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gene Shears Pty Ltd filed Critical Gene Shears Pty Ltd
Publication of GR3015374T3 publication Critical patent/GR3015374T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/10—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
    • A01N57/16—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds containing heterocyclic radicals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/60—Isolated nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/121—Hammerhead
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/124—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes based on group I or II introns

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
GR940403895T 1987-12-15 1995-03-13 Ribozymes. GR3015374T3 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPI591187 1987-12-15
AUPI995088 1988-08-19
AUPJ035388 1988-09-09
AUPJ130488 1988-11-04
AUPJ133388 1988-11-07

Publications (1)

Publication Number Publication Date
GR3015374T3 true GR3015374T3 (en) 1995-06-30

Family

ID=27507391

Family Applications (1)

Application Number Title Priority Date Filing Date
GR940403895T GR3015374T3 (en) 1987-12-15 1995-03-13 Ribozymes.

Country Status (19)

Country Link
EP (2) EP0321201B2 (en)
JP (1) JP3046318B2 (en)
KR (1) KR970010758B1 (en)
CN (1) CN1102174C (en)
AR (1) AR243935A1 (en)
AT (1) ATE115999T1 (en)
AU (1) AU632993B2 (en)
CA (1) CA1340831C (en)
DE (1) DE3852539T3 (en)
DK (1) DK175956B1 (en)
ES (1) ES2065919T5 (en)
FI (1) FI104562B (en)
GR (1) GR3015374T3 (en)
HU (2) HUT54407A (en)
MC (1) MC2115A1 (en)
NO (2) NO308610B1 (en)
NZ (1) NZ227332A (en)
RO (1) RO114469B1 (en)
WO (1) WO1989005852A1 (en)

Families Citing this family (183)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019556A (en) * 1987-04-14 1991-05-28 President And Fellows Of Harvard College Inhibitors of angiogenin
US5866701A (en) * 1988-09-20 1999-02-02 The Board Of Regents For Northern Illinois University Of Dekalb HIV targeted hairpin ribozymes
CA1340323C (en) * 1988-09-20 1999-01-19 Arnold E. Hampel Rna catalyst for cleaving specific rna sequences
US5168053A (en) * 1989-03-24 1992-12-01 Yale University Cleavage of targeted RNA by RNAase P
US5624824A (en) * 1989-03-24 1997-04-29 Yale University Targeted cleavage of RNA using eukaryotic ribonuclease P and external guide sequence
DE4091533T (en) * 1989-08-31 1992-01-30
US5225347A (en) * 1989-09-25 1993-07-06 Innovir Laboratories, Inc. Therapeutic ribozyme compositions and expression vectors
US5225337A (en) * 1989-09-25 1993-07-06 Innovir Laboratories, Inc. Ribozyme compositions and methods for use
DE3933384A1 (en) * 1989-10-06 1991-04-18 Hoechst Ag MULTIFUNCTIONAL RNA WITH SELF-PROCESSING ACTIVITY, THEIR PRODUCTION AND THEIR USE
DE3935473A1 (en) * 1989-10-25 1991-05-02 Hoechst Ag RNA WITH ENDONUCLEASE AND ANTISENSE ACTIVITY, THEIR PRODUCTION AND THEIR USE
DE69133405T2 (en) * 1990-01-11 2005-07-07 Isis Pharmaceutical, Inc., Carlsbad Oligonucleotide derivatives for detecting and modulating RNA activity and gene expression
DE4002885A1 (en) * 1990-02-01 1991-08-08 Hoechst Ag EXPRESSION OF A MULTIPLE RNA WITH SELF-SPLICING ACTIVITY
US5519164A (en) * 1990-02-01 1996-05-21 Hoechst Aktiengesellschaft Expression of a multigene RNA having self-splicing activity
US5180818A (en) * 1990-03-21 1993-01-19 The University Of Colorado Foundation, Inc. Site specific cleavage of single-stranded dna
AU7152191A (en) * 1990-06-07 1991-12-31 City Of Hope Ribozyme mediated reversal of transformation by cleavage of the hras oncogene rna
WO1991018913A1 (en) * 1990-06-07 1991-12-12 City Of Hope Ribozyme mediated reversal of transformation by cleavage of the hras oncogene rna
EP0535067B1 (en) * 1990-06-19 1997-03-26 Gene Shears Pty. Ltd. Endonucleases
US6008343A (en) * 1990-06-19 1999-12-28 Gene Shears Pty. Ltd. Nucleotide based endonucleases
WO1992000080A1 (en) * 1990-06-26 1992-01-09 The Wistar Institute Of Anatomy & Biology Method for treating leukemias
US5246921A (en) * 1990-06-26 1993-09-21 The Wistar Institute Of Anatomy And Biology Method for treating leukemias
AU8294291A (en) * 1990-07-26 1992-02-18 Foundation For Research And Technology - Hellas (Fo.R.T.H.) Institute Of Molecular Biology & Biotechnology Portable ribozyme cassettes, dna sequences containing them, ribozymes encoded by these dna sequences, and compositions containing these ribozymes
WO1992007065A1 (en) * 1990-10-12 1992-04-30 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Modified ribozymes
NZ314630A (en) * 1991-01-17 2000-11-24 Harvard College Use of trans-splicing ribozymes for genetic modification and cell ablation in a host cell
NZ314629A (en) * 1991-01-17 2000-08-25 Gen Hospital Corp Use trans-splicing ribozymes to prepare medicaments for gene therapies
FR2675803B1 (en) * 1991-04-25 1996-09-06 Genset Sa CLOSED, ANTISENSE AND SENSE OLIGONUCLEOTIDES AND THEIR APPLICATIONS.
FI913197A0 (en) 1991-07-01 1991-07-01 Xyrofin Oy THEREFORE A REDUCED MEASURE AT THE METABOLISER OF XYLITOL, FOERFARANDE FOER BILDANDE AV DESSA OCH DERAS ANVAENDNING VID FRAMSTAELLNING AV XYLITOL.
CA2127461A1 (en) * 1992-01-13 1993-07-22 Michael D. Been Enzymatic rna molecules
CA2111565A1 (en) * 1992-04-17 1993-10-28 Isao Ishida Plants resistant against plural viruses and method for producing them
PT652705E (en) * 1992-06-29 2006-05-31 Gene Shears Pty Ltd NUCLEIC ACIDS AND METHODS FOR THEIR USE IN COMBATING VIRAL PATHOGENS
WO1994001549A1 (en) * 1992-07-02 1994-01-20 Sankyo Company, Limited Looped, hairpin ribozyme
US5409823A (en) * 1992-09-24 1995-04-25 Ciba-Geigy Corporation Methods for the production of hybrid seed
US5864028A (en) * 1992-11-03 1999-01-26 Gene Shears Pty. Limited Degradation resistant mRNA derivatives linked to TNF-α ribozymes
IL107480A0 (en) * 1992-11-03 1994-02-27 Gene Shears Pty Ltd Tnf-x ribozymes and degradation resistant mrna derivatives linked to tnf-x ribozymes
US6080851A (en) * 1992-12-04 2000-06-27 American Home Products Corporation Ribozymes with linked anchor sequences
DE69331911T2 (en) * 1992-12-04 2002-11-21 Ribozyme Pharmaceuticals, Inc. DIAGNOSTICS BY SIGNAL ENHANCEMENT THROUGH A RIBOZYME
AU679525B2 (en) * 1992-12-04 1997-07-03 Innovir Laboratories, Inc. Regulatable nucleic acid therapeutic and methods of use thereof
FR2701960B1 (en) * 1993-02-26 2002-09-13 Gene Shears Pty Ltd Polyribozyme able to confer on plants resistance to viruses and resistant plants producing this polyribozyme.
US5817635A (en) * 1993-08-09 1998-10-06 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Modified ribozymes
WO1995010608A1 (en) * 1993-10-15 1995-04-20 Foundation For Research And Technology - Hellas (Fo.R.T.H.) Asymmetric hammerhead ribozymes and nucleotide sequences for their construction
US5869248A (en) * 1994-03-07 1999-02-09 Yale University Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences
US5998193A (en) * 1994-06-24 1999-12-07 Gene Shears Pty., Ltd. Ribozymes with optimized hybridizing arms, stems, and loops, tRNA embedded ribozymes and compositions thereof
US6350934B1 (en) 1994-09-02 2002-02-26 Ribozyme Pharmaceuticals, Inc. Nucleic acid encoding delta-9 desaturase
US6057153A (en) * 1995-01-13 2000-05-02 Yale University Stabilized external guide sequences
US5683873A (en) * 1995-01-13 1997-11-04 Innovir Laboratories, Inc. EGS-mediated inactivation of target RNA
FR2730637B1 (en) 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa PHARMACEUTICAL COMPOSITION CONTAINING NUCLEIC ACIDS, AND USES THEREOF
US6004806A (en) * 1995-06-07 1999-12-21 Commonwealth Scientific And Industrial Research Organization Optimized minizymes and miniribozymes and uses thereof
JPH11506914A (en) * 1995-06-07 1999-06-22 コモンウェルス・サイエンティフィック・アンド・インダストリアル・リサーチ・オーガニゼーション Optimized minizymes and miniribozymes and uses thereof
US6010904A (en) * 1995-06-07 2000-01-04 The General Hospital Corporation Cell ablation using trans-splicing ribozymes
AU6761796A (en) * 1995-07-13 1997-04-01 Dowelanco Compositions and method for modulation of gene expression in plants
US5824519A (en) * 1995-11-08 1998-10-20 Medical University Of South Carolina Tissue-specific and target RNA-specific ribozymes
US6620805B1 (en) 1996-03-14 2003-09-16 Yale University Delivery of nucleic acids by porphyrins
US5877162A (en) * 1996-03-14 1999-03-02 Innovir Laboratories, Inc. Short external guide sequences
US6610478B1 (en) 1996-08-16 2003-08-26 Yale University Phenotypic conversion of cells mediated by external guide sequences
US5976874A (en) * 1996-08-16 1999-11-02 Yale University Phenotypic conversion of drug-resistant bacteria to drug-sensitivity
US6884430B1 (en) 1997-02-10 2005-04-26 Aventis Pharma S.A. Formulation of stabilized cationic transfection agent(s) /nucleic acid particles
US6969601B2 (en) 1997-04-03 2005-11-29 Jensenius Jens Chr MASP-2, a complement-fixing enzyme, and uses for it
US7589253B2 (en) 1997-04-15 2009-09-15 Commonwealth Scientific And Industrial Research Organisation Fatty acid epoxygenase genes from plants and uses therefor in modifying fatty acid metabolism
KR100711074B1 (en) 1997-04-15 2007-04-26 커먼웰쓰 사이언티픽 앤드 인더스트리얼 리서치 오가니제이션 Plant fatty acid epoxygenase genes and uses therefor
CN1261807A (en) 1997-06-30 2000-08-02 罗纳-布朗克罗莱尔股份有限公司 Improved method for transferring nucleic acids into striated muscle and combination for carrying out the method
WO1999014331A2 (en) 1997-09-16 1999-03-25 Cropdesign Nv Cyclin-dependent kinase inhibitors and uses thereof
DE19741375C2 (en) * 1997-09-19 1999-10-21 Max Planck Gesellschaft Transgenic plants, the above-ground parts of which ripen earlier and die off completely
JP4891477B2 (en) 1997-10-02 2012-03-07 マックス−プランク−ゲゼルシャフト ツール フォーデルング デル ヴィッセンシャフテン エー．ヴェー． Methods for the regulation of angiogenesis and / or development of side arteries and / or other arteries from existing arteriole networks
AU1671199A (en) 1997-11-18 1999-06-07 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Nucleic acids involved in the responder phenotype and applications thereo
US6013447A (en) * 1997-11-21 2000-01-11 Innovir Laboratories, Inc. Random intracellular method for obtaining optimally active nucleic acid molecules
KR101054060B1 (en) 1998-03-20 2011-08-04 커먼웰쓰 사이언티픽 앤드 인더스트리얼 리서치 오가니제이션 Control of gene expression
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
US6248525B1 (en) 1998-03-30 2001-06-19 Yale University Method for identifying essential or functional genes
AU4830899A (en) 1998-06-24 2000-01-10 Musc Foundation For Research Development Tissue-specific and target rna-specific ribozymes
DE19836098A1 (en) 1998-07-31 2000-02-03 Hoechst Schering Agrevo Gmbh Plants that synthesize a modified starch, process for producing the plants, their use and the modified starch
DE69938190T2 (en) 1998-10-15 2009-03-05 Novartis Vaccines and Diagnostics, Inc., Emeryville GENES WITH CHANGED EXPRESSION IN METASTIC BREAST OR THICK-DARM CANCER CELLS
CN100408687C (en) * 1998-11-09 2008-08-06 拜尔生物科学有限公司 Nucleic acid molecules from rice and their use for the prodn. of modified starch
EP2336336B1 (en) 1998-11-12 2014-04-23 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof
ATE408695T1 (en) 1998-12-16 2008-10-15 Novartis Vaccines & Diagnostic HUMAN CYCLIN DEPENDENT KINASE (HPNQALRE)
US6271359B1 (en) 1999-04-14 2001-08-07 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
AUPQ005299A0 (en) 1999-04-29 1999-05-27 Commonwealth Scientific And Industrial Research Organisation Novel genes encoding wheat starch synthases and uses therefor
ATE305718T1 (en) 1999-07-20 2005-10-15 Gvs Ges Fuer Erwerb Und Verwer NEW METHOD FOR THE PRODUCTION AND SELECTION OF TRANSGENIC FLAT PLANTS AND FLAX SEEDS
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
PT2364734T (en) 2000-07-21 2017-10-04 Revance Therapeutics Inc Multi-component biological transport systems
PT1331845E (en) 2000-11-09 2012-04-12 Commw Scient Ind Res Org Barley with reduced ssii activity and starch containing products with a reduced amylopectin content
ITMI20011364A1 (en) * 2001-06-28 2002-12-28 Metapontum Agrobios S C R L ROBOZIMA HAMMERHEAD SPECIFIC FOR STEAROYL-ACP DESATURESI OF DIFFERENT OILAGINOUS PLANTS
KR101015913B1 (en) 2001-07-10 2011-02-23 존슨 앤드 존슨 리서치 피티와이 리미티드 Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells
US7994144B2 (en) 2001-07-10 2011-08-09 Johnson & Johnson Research Pty, Limited Process for the preparation of a composition of genetically modified hematopoietic progenitor cells
US8022272B2 (en) 2001-07-13 2011-09-20 Sungene Gmbh & Co. Kgaa Expression cassettes for transgenic expression of nucleic acids
FR2829136B1 (en) 2001-08-29 2006-11-17 Aventis Pharma Sa LIPID DERIVATIVES OF AMINOGLYCOSIDES
US7456335B2 (en) 2001-09-03 2008-11-25 Basf Plant Science Gmbh Nucleic acid sequences and their use in methods for achieving pathogen resistance in plants
EP2284195A1 (en) 2001-09-18 2011-02-16 Carnegie Institution Of Washington Fusion proteins useful for detecting analytes
AU2002359761A1 (en) 2001-12-18 2003-06-30 Invenux, Inc. Antibiotic compounds
US20040005546A1 (en) 2002-02-28 2004-01-08 Oncolytics Biotech Inc. Use of ribozymes in the detection of adventitious agents
DE10212892A1 (en) 2002-03-20 2003-10-09 Basf Plant Science Gmbh Constructs and methods for regulating gene expression
EP1365034A3 (en) 2002-05-21 2004-02-18 Bayer HealthCare AG Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasia
US7771952B2 (en) 2002-06-26 2010-08-10 Abott Laboratories Modulators and modulation of the interaction between RGM and Neogenin
EP2036984B1 (en) 2002-07-26 2012-02-22 BASF Plant Science GmbH Reversion of the negative selective effect of negative marker proteins as selection procedure
DE60334246D1 (en) 2002-11-21 2010-10-28 Celltech R & D Inc MODULATE IMMUNE RESPONSES
WO2004056999A1 (en) 2002-12-19 2004-07-08 Bayer Cropscience Gmbh Plant cells and plants which synthesize a starch with an increased final viscosity
HUE024996T2 (en) 2003-05-12 2016-01-28 Helion Biotech Aps Antibodies to masp-2
JP4923171B2 (en) 2003-06-30 2012-04-25 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイション Wheat with modified branching enzyme activity, and starch and starch-containing products obtained therefrom
EP1892306A3 (en) 2003-10-06 2008-06-11 Bayer HealthCare AG Methods and kits for investigating cancer
EP1602926A1 (en) 2004-06-04 2005-12-07 University of Geneva Novel means and methods for the treatment of hearing loss and phantom hearing
US7604947B2 (en) 2004-06-09 2009-10-20 Cornell Research Foundation, Inc. Detection and modulation of cancer stem cells
EP2386317A1 (en) 2004-06-10 2011-11-16 Omeros Corporation Methods for treating conditions associated with MASP-2 dependent complement activation
US8840893B2 (en) 2004-06-10 2014-09-23 Omeros Corporation Methods for treating conditions associated with MASP-2 dependent complement activation
US7919094B2 (en) 2004-06-10 2011-04-05 Omeros Corporation Methods for treating conditions associated with MASP-2 dependent complement activation
WO2006005520A2 (en) 2004-07-08 2006-01-19 Dlf-Trifolium A/S Means and methods for controlling flowering in plants
CA2573986C (en) 2004-08-02 2013-11-26 Basf Plant Science Gmbh Transcription termination sequence and use thereof
CA2579927A1 (en) 2004-09-24 2006-03-30 Basf Plant Science Gmbh Plant cells and plants with increased tolerance to environmental stress
JP5638736B2 (en) 2004-12-30 2014-12-10 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション Methods and means for improving intestinal health
EP1707632A1 (en) 2005-04-01 2006-10-04 Bayer CropScience GmbH Phosphorylated waxy potato starch
US8906864B2 (en) 2005-09-30 2014-12-09 AbbVie Deutschland GmbH & Co. KG Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use
WO2007054441A2 (en) 2005-11-08 2007-05-18 Basf Plant Science Gmbh Use of armadillo repeat (arm1) polynucleotides for obtaining pathogen resistance in plants
AU2007204341B2 (en) 2006-01-12 2012-10-04 Basf Plant Science Gmbh Use of stomatin (STM1) polynucleotides for achieving a pathogen resistance in plants
WO2008034648A1 (en) 2006-04-05 2008-03-27 Metanomics Gmbh Process for the production of a fine chemical
EP2030021B1 (en) 2006-05-18 2012-11-21 Andreas Reichert Method for diagnosing mitochondrial dysfunction
US8383597B2 (en) 2006-05-25 2013-02-26 Cornell Research Foundation, Inc. G proteins in tumor growth and angiogenesis
AU2007304837B2 (en) 2006-10-06 2011-09-29 Speedx Pty Ltd Molecular switches and methods for their use
CA2673361A1 (en) 2007-01-15 2008-07-24 Basf Plant Science Gmbh Use of subtilisin (rnr9) polynucleotides for achieving a pathogen resistance in plants
AU2008214568B2 (en) 2007-02-16 2013-04-18 Basf Plant Science Gmbh Nucleic acid sequences for regulation of embryo-specific expression in monocotyledonous plants
MX2009010450A (en) 2007-03-27 2009-11-23 Omeros Corp The use of pde7 inhibitors for the treatment of movement disorders.
WO2008142036A2 (en) 2007-05-22 2008-11-27 Basf Plant Science Gmbh Plant cells and plants with increased tolerance and/or resistance to environmental stress and increased biomass production-ko
CL2008002775A1 (en) 2007-09-17 2008-11-07 Amgen Inc Use of a sclerostin binding agent to inhibit bone resorption.
EP2040075A1 (en) 2007-09-24 2009-03-25 Julius-Maximilians-Universität Würzburg Compounds and markers for surface-enhanced raman scattering
CN101896201A (en) 2007-12-14 2010-11-24 安进公司 Method for treating bone fracture with anti-sclerostin antibodies
WO2009080743A2 (en) 2007-12-21 2009-07-02 Basf Plant Science Gmbh Plants with increased yield (ko nue)
US8962803B2 (en) 2008-02-29 2015-02-24 AbbVie Deutschland GmbH & Co. KG Antibodies against the RGM A protein and uses thereof
EP2100962A1 (en) 2008-03-12 2009-09-16 Biogemma Plants having improved resistance to pathogens
US10517839B2 (en) 2008-06-09 2019-12-31 Cornell University Mast cell inhibition in diseases of the retina and vitreous
US8790664B2 (en) 2008-09-05 2014-07-29 Institut National De La Sante Et De La Recherche Medicale (Inserm) Multimodular assembly useful for intracellular delivery
EP2184351A1 (en) 2008-10-30 2010-05-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Polynucleotides encoding caryophyllene synthase and uses thereof
ES2363358B1 (en) 2009-04-03 2012-06-21 FUNDACIÓ INSTITUT DE RECERCA HOSPITAL UNIVERSITARI VALL D'HEBRON (Titular al THERAPEUTIC AGENTS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AN INDESEABLE CELLULAR PROLIFERATION.
CA3020943A1 (en) 2009-04-22 2010-10-28 Basf Plant Science Company Gmbh Whole seed specific promoter
EP2475367A1 (en) 2009-09-10 2012-07-18 Centre National De La Recherche Scientifique NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES
EP2305285A1 (en) 2009-09-29 2011-04-06 Julius-Maximilians-Universität Würzburg Means and methods for treating ischemic conditions
BR112012008970A2 (en) 2009-10-16 2019-12-10 Omeros Corp use of a composition and composition
CN102812014B (en) 2009-10-30 2016-01-20 多美恩医疗公司 The purposes of novel 9 oxime derivate and the allosteric modulators as metabotropic glutamate receptor thereof
EP2322149A1 (en) 2009-11-03 2011-05-18 Universidad del Pais Vasco Methods and compositions for the treatment of ischemia
AU2010329955A1 (en) 2009-12-08 2012-05-24 Abbott Gmbh & Co. Kg Monoclonal antibodies against the RGM A protein for use in the treatment of retinal nerve fiber layer degeneration
EP2338492A1 (en) 2009-12-24 2011-06-29 Universidad del Pais Vasco Methods and compositions for the treatment of alzheimer
US8476485B2 (en) 2010-06-24 2013-07-02 Academia Sinica Non-human animal model for amyotrophic lateral sclerosis (ALS) with loss-of-TDP-43 function
EP2640395A4 (en) 2010-11-08 2014-01-22 Omeros Corp Treatment of addiction and impulse-control disorders using pde7 inhibitors
US9220715B2 (en) 2010-11-08 2015-12-29 Omeros Corporation Treatment of addiction and impulse-control disorders using PDE7 inhibitors
NZ709997A (en) 2011-04-08 2016-03-31 Univ Leicester Methods for treating conditions associated with masp-2 dependent complement activation
US9644035B2 (en) 2011-04-08 2017-05-09 Omeros Corporation Methods for treating conditions associated with MASP-2 dependent complement activation
US10323236B2 (en) 2011-07-22 2019-06-18 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
US20150017091A1 (en) 2011-08-18 2015-01-15 Cornell University Detection and treatment of metastatic disease
WO2013039880A1 (en) 2011-09-12 2013-03-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Biomarkers and therapeutic targets of hepatocellular cancer
US10428342B2 (en) 2011-12-16 2019-10-01 Board Of Trustees Of Michigan State University P-coumaroyl-CoA:monolignol transferase
RU2644337C2 (en) 2012-01-27 2018-02-08 Эббви Дойчланд Гмбх Унд Ко. Кг Compositions and methods for diagnostics and treatment of diseases associated with neurites degeneration
WO2013138463A1 (en) 2012-03-14 2013-09-19 University Of Central Florida Research Foundation, Inc. Neurofibromatoses therapeutic agents and screening for same
EP2666775A1 (en) 2012-05-21 2013-11-27 Domain Therapeutics Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors
WO2014127835A1 (en) 2013-02-22 2014-08-28 Christian-Albrechts-Universität Zu Kiel Plant-derived resistance gene
US20150044192A1 (en) 2013-08-09 2015-02-12 President And Fellows Of Harvard College Methods for identifying a target site of a cas9 nuclease
CA2926385A1 (en) 2013-10-17 2015-04-23 Omeros Corporation Methods for treating thrombotic microangiopathies associated with masp-2dependent complement activation
UA122768C2 (en) 2013-12-18 2021-01-06 Коммонвелз Сайнтіфік Енд Індастріал Рисерч Организейшн Lipid comprising long chain polyunsaturated fatty acids
AU2015281791A1 (en) 2014-06-27 2017-01-12 Commonwealth Scientific And Industrial Research Organisation Lipid comprising docosapentaenoic acid
EP3000814A1 (en) 2014-09-26 2016-03-30 Domain Therapeutics Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors
SG10202104041PA (en) 2015-10-23 2021-06-29 Harvard College Nucleobase editors and uses thereof
IL295200A (en) 2015-11-09 2022-10-01 Omeros Corp Compositions comprising masp-2 inhibitory antibodies and antigen-binding fragments thereof for use in treating plasma therapy-resistant ahus
KR102564616B1 (en) 2016-01-05 2023-08-08 유니버시티 오브 레스터 Methods for inhibiting fibrosis in a subject in need thereof
KR20230019991A (en) 2016-03-31 2023-02-09 오메로스 코포레이션 Methods for inhibiting angiogenesis in a subject in need thereof
BR112018074101A2 (en) 2016-05-26 2019-03-06 Nunhems Bv seedless fruit plants
CA3032699A1 (en) 2016-08-03 2018-02-08 President And Fellows Of Harvard College Adenosine nucleobase editors and uses thereof
CA3033327A1 (en) 2016-08-09 2018-02-15 President And Fellows Of Harvard College Programmable cas9-recombinase fusion proteins and uses thereof
US11542509B2 (en) 2016-08-24 2023-01-03 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
WO2018129544A1 (en) 2017-01-09 2018-07-12 Whitehead Institute For Biomedical Research Methods of altering gene expression by perturbing transcription factor multimers that structure regulatory loops
US11898179B2 (en) 2017-03-09 2024-02-13 President And Fellows Of Harvard College Suppression of pain by gene editing
US10883089B2 (en) 2017-04-04 2021-01-05 Wisconsin Alumni Research Foundation Feruloyl-CoA:monolignol transferases
US10883090B2 (en) 2017-04-18 2021-01-05 Wisconsin Alumni Research Foundation P-coumaroyl-CoA:monolignol transferases
EP3655015B1 (en) 2017-07-17 2024-02-21 The Regents of the University of Colorado Compositions and methods for preventing and treating radiation-induced bystander effects caused by radiation or radiotherapy
JP2020534795A (en) 2017-07-28 2020-12-03 プレジデント アンド フェローズ オブ ハーバード カレッジ Methods and Compositions for Evolving Base Editing Factors Using Phage-Supported Continuous Evolution (PACE)
TW202402809A (en) 2017-08-15 2024-01-16 美商歐米諾斯公司 Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant
EP3676376A2 (en) 2017-08-30 2020-07-08 President and Fellows of Harvard College High efficiency base editors comprising gam
KR20200121782A (en) 2017-10-16 2020-10-26 더 브로드 인스티튜트, 인코퍼레이티드 Uses of adenosine base editor
US11584714B2 (en) 2018-05-29 2023-02-21 Omeros Corporation MASP-2 inhibitors and methods of use
EP3806619A1 (en) 2018-06-15 2021-04-21 Nunhems B.V. Seedless watermelon plants comprising modifications in an abc transporter gene
BR112021007864A2 (en) 2018-11-09 2021-08-10 Wisconsin Alumni Research Foundation recombinant nucleic acid, methods and fertile transgenic plant
KR20210142210A (en) 2019-03-19 2021-11-24 더 브로드 인스티튜트, 인코퍼레이티드 Methods and compositions for editing nucleotide sequences
IL293588A (en) 2019-12-04 2022-08-01 Omeros Corp Masp-2 inhibitor compounds, compositions comprising same and uses thereof
US11807641B2 (en) 2019-12-04 2023-11-07 Omeros Corporation MASP-2 inhibitors and methods of use
WO2021113698A1 (en) 2019-12-04 2021-06-10 Omeros Corporation Masp-2 inhibitors and methods of use
JP2023525304A (en) 2020-05-08 2023-06-15 ザ ブロード インスティテュート，インコーポレーテッド Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
EP4192952A1 (en) 2020-08-10 2023-06-14 Novartis AG Treatments for retinal degenerative diseases
WO2024038089A1 (en) 2022-08-18 2024-02-22 Mitodicure Gmbh Use of a therapeutic agent with phosphodiesterase-7 inhibitory activity for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance
WO2024042160A1 (en) 2022-08-26 2024-02-29 Mitodicure Gmbh Use of a therapeutic agent with sodium-hydrogen antiporter 1 inhibitory activity for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116742A (en) * 1986-12-03 1992-05-26 University Patents, Inc. RNA ribozyme restriction endoribonucleases and methods
US4987071A (en) * 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
DE3642623A1 (en) * 1986-12-13 1988-06-23 Burbach & Bender Ohg GAS PURGE FOR METALLURGICAL VESSELS
DE3939771A1 (en) * 1989-12-01 1991-06-06 Behringwerke Ag PROCESS FOR THE BIOLOGICAL INACTIVATION OF NUCLEIC ACIDS

Also Published As

Publication number Publication date
DE3852539T3 (en) 2005-08-04
EP0321201B2 (en) 2004-11-24
AU632993B2 (en) 1993-01-21
HU211891A9 (en) 1995-12-28
DK175956B1 (en) 2005-08-22
EP0321201A3 (en) 1990-01-10
NO20000369L (en) 1990-08-14
CN1033838A (en) 1989-07-12
HUT54407A (en) 1991-02-28
DE3852539D1 (en) 1995-02-02
NO902661D0 (en) 1990-06-14
EP0321201B1 (en) 1994-12-21
JPH03502638A (en) 1991-06-20
WO1989005852A1 (en) 1989-06-29
EP0640688A1 (en) 1995-03-01
DK143390A (en) 1990-08-14
KR970010758B1 (en) 1997-06-30
EP0321201A2 (en) 1989-06-21
CN1102174C (en) 2003-02-26
AR243935A1 (en) 1993-09-30
ES2065919T3 (en) 1995-03-01
DE3852539T2 (en) 1995-05-04
AU2800789A (en) 1989-07-19
CA1340831C (en) 1999-11-30
KR900700603A (en) 1990-08-16
FI104562B (en) 2000-02-29
NO902661L (en) 1990-08-14
NO20000369D0 (en) 2000-01-25
ATE115999T1 (en) 1995-01-15
DK143390D0 (en) 1990-06-12
FI902923A0 (en) 1990-06-12
MC2115A1 (en) 1991-07-05
NZ227332A (en) 1991-08-27
NO308610B1 (en) 2000-10-02
JP3046318B2 (en) 2000-05-29
NO312105B1 (en) 2002-03-18
RO114469B1 (en) 1999-04-30
ES2065919T5 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
GR3015374T3 (en) Ribozymes.
DE3863660D1 (en) Aminomethylheterocyclen.
DE3864664D1 (en) Koerperstativ.
DE3866200D1 (en) Oelablassventil.
DE3854331D1 (en) Eisnachweisschaltung.
DE3866723D1 (en) Thermoplastische polyamidformmassen.
DE3765420D1 (en) Huelsengummifeder.
DE3852484D1 (en) Ionomerzubereitung.
DE3862796D1 (en) Emp - generator.
DE3875006D1 (en) Waermepumpensystem.
DE3876364D1 (en) Muenzbehandlungsvorrichtung.
DE3874785D1 (en) Duennfilmkondensator.
DE3867135D1 (en) Thermo-transferdrucker.
DE3868170D1 (en) Polyurethanklebstoff.
DE3860893D1 (en) Waescheweichmacherzusammensetzung.
DE3868953D1 (en) Heckbruecke.
DE3861059D1 (en) Antihypercholesterin-beta-lactone.
DE3866184D1 (en) Buten-1-copolymer.
DE3852648D1 (en) Hypersystolischer reed-solomon-encoder.
DE3769639D1 (en) Tuerschliesser.
DE3873965D1 (en) Rotations-hydraulikmaschine.
DE3867371D1 (en) Gate-turn-off-thyristor.
DE3868441D1 (en) Relaxationsoszillator.
DE3866984D1 (en) Phenoxypropanolamine.
DE3850382D1 (en) Polyester-film.